Press Release

Dechert Welcomes Employee Benefits and Executive Compensation Partner Kevin Kay in New York

Issued by Dechert LLP

Sept. 8, 2021

Dechert LLP announced today that Kevin Kay has joined the firm’s employee benefits and executive compensation group as a partner based in New York. 

Mr. Kay regularly advises public and private clients on a wide variety of executive compensation, employment, and benefits issues. He has particular experience in the transactional space, including strategically advising on private equity and cross-border M&A transactions, as well as spinoffs, IPOs, and other complex corporate transactions. He received a J.D., magna cum laude, from Hofstra University and a B.S., summa cum laude, from Molloy College.

David Jones, co-chair of Dechert’s employee benefits and executive compensation group, commented, “Kevin’s deep transactional experience, especially on sophisticated PE and M&A transactions, will align with the needs of our international client base. He is a terrific addition to our group and we’re excited to welcome him to the firm.”

Mr. Kay commented, “I’m thrilled to be joining Dechert and look forward to working with my new colleagues around the world on dynamic and innovative transactions and matters for our clients.”

Dechert’s employee benefits and executive compensation practice group serves a wide variety of clients, including large multinational corporations, high-technology start-ups and some of the world’s largest financial organizations. The firm, including the employee benefits and executive compensation group, has been recognized among leading law firms by Chambers USA and The Legal 500 (U.S.).

About Dechert

Dechert is a leading global law firm with 22 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.